Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02KBD
|
|||
| Drug Name |
Mebutamate
|
|||
| Synonyms |
Dormate
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Anxiety disorder [ICD-11: 6B00-6B0Z; ICD-10: F40-F42] | Approved | [1] | |
| Company |
Medpointe Pharmaceuticals Medpointe Healthcare Inc
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C10H20N2O4
|
|||
| Canonical SMILES |
CCC(C)C(C)(COC(=O)N)COC(=O)N
|
|||
| InChI |
1S/C10H20N2O4/c1-4-7(2)10(3,5-15-8(11)13)6-16-9(12)14/h7H,4-6H2,1-3H3,(H2,11,13)(H2,12,14)
|
|||
| InChIKey |
LEROTMJVBFSIMP-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 64-55-1
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:31804
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | GABA(A) receptor gamma-3 (GABRG3) | Target Info | Modulator | [2] |
| KEGG Pathway | Neuroactive ligand-receptor interaction | |||
| Retrograde endocannabinoid signaling | ||||
| GABAergic synapse | ||||
| Morphine addiction | ||||
| Nicotine addiction | ||||
| Reactome | Ligand-gated ion channel transport | |||
| GABA A receptor activation | ||||
| WikiPathways | SIDS Susceptibility Pathways | |||
| Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell | ||||
| Iron uptake and transport | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
| REF 2 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.